United Therapeutics (UTHR) Ownership - Who owns United Therapeutics?

9 days until earnings call

Profile

Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
14.6B
P/E Ratio
15.59
Total Cash
N/A
Projected Growth
2.45
Total Debt
600M
Revenue
2.5B
Risk (Beta)
0.80
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
21.97
Revenue/Share
50.24 USD as % of share price

Fundamentals

UTHR
Capitalization
14.6B
P/E Ratio
15.59
Risk (Beta)
0.80
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
600M
Total Debt/Equity
21.97
Projected Growth (PEG Ratio)
2.45
Revenue/Share (as % of the share price)
50.24%
Revenue
2.5B
ROE
N/A
Book Value
5.34B
P/B Ratio
2.74
Cash Flow
N/A
Earnings
22.36
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
700K
Current Ratio
3.77
Current Revenue Per Employee
580222.60
Dividends Per Share - Security
N/A
EBITDA
1.5B
Float
N/A
Float - Current
N/A
Gross Income Margin
89.24
Revenue To Assets
16.36
Shares Held By Institutions
32.3B
Shares Outstanding - Current
44.4M
Total Liabilities
1.16B
Total Volume MTD
N/A
Value
-1
Gain YTD
49.693
View a ticker or compare two or three
UTHR
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com